Argentina Pharmacovigilance Market Size & Outlook, 2026-2033
The pharmacovigilance market in Argentina is expected to reach a projected revenue of US$ 62.2 million by 2033. A compound annual growth rate of 4.6% is expected of Argentina pharmacovigilance market from 2026 to 2033.
The Argentina pharmacovigilance market generated a revenue of USD 42.7 million in 2025 and is expected to reach USD 62.2 million by 2033.
The Argentina market is expected to grow at a CAGR of 4.6% from 2026 to 2033.
In terms of segment, phase iv was the largest revenue generating product life cycle in 2025.
Phase IV is the most lucrative product life cycle segment registering the fastest growth during the forecast period.
Pharmacovigilance market data book summary
Market revenue in 2025
USD 42.7 million
Market revenue in 2033
USD 62.2 million
Growth rate
4.6% (CAGR from 2026 to 2033)
Largest segment
Phase iv
Fastest growing segment
Phase IV
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Pre Clinical, Phase I, Phase II, Phase III, Phase IV
Key market players worldwide
Accenture PLC Class A, IQVIA Holdings Inc, Cognizant Technology Solutions Corp Class A, Linical Americas, International Business Machines Corp, Labcorp Holdings Inc, ArisGlobal, Capgemini SE, ITClinical, Icon PLC, TAKE Solutions, PAREXEL, Wipro Ltd ADR, United Biosource Corporation, FMD K&L, BioClinica
Other key industry trends
In terms of revenue, Argentina accounted for 0.5% of the global pharmacovigilance market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Latin America, Brazil pharmacovigilance market is projected to lead the regional market in terms of revenue in 2033.
Mexico is the fastest growing regional market in Latin America and is projected to reach USD 156.9 million by 2033.
The market growth in Argentina can be attributed to the rising patient awareness regarding pharmacovigilance, increasing prevalence of chronic diseases, and the ease of access to pharmaceuticals. Moreover, rising government efforts to provide advanced healthcare facilities in underdeveloped areas of the country are anticipated to fuel market growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmacovigilance Market Outlook will help companies and investors design strategic landscapes.
Phase Iv was the largest segment with a revenue share of 80.8% in 2025.
Horizon Databook has segmented the Argentina pharmacovigilance market based on pre clinical, phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2021 to 2033.
The market growth in Argentina can be attributed to the rising patient awareness regarding pharmacovigilance, increasing prevalence of chronic diseases, and the ease of access to pharmaceuticals. Moreover, rising government efforts to provide advanced healthcare facilities in underdeveloped areas of the country are anticipated to fuel market growth.
Argentina Pharmacovigilance Market Product Life Cycle Outlook (Revenue, USD Million , 2021-2033)
Pre Clinical
Phase I
Phase II
Phase III
Phase IV
Argentina Pharmacovigilance Market Service Provider Outlook (Revenue, USD Million , 2021-2033)
In House
Contract outsourcing
Argentina Pharmacovigilance Market Type Outlook (Revenue, USD Million , 2021-2033)
Spontaneous reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Argentina Pharmacovigilance Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceuticals
Biotechnology Companies
Medical Device Manufacturers
Others
Argentina Pharmacovigilance Market Therapeutic Area Outlook (Revenue, USD Million , 2021-2033)
Oncology
Neurology
Cardiology
Respiratory Systems
Others
Argentina Pharmacovigilance Market Process Flow Outlook (Revenue, USD Million , 2021-2033)
Case Data Management
Signal Detection
Risk Management System
Reasons to subscribe to Pharmacovigilance Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pharmacovigilance Market Outlook databook
Our clientele includes a mix of Pharmacovigilance Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Pharmacovigilance Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Argentina Pharmacovigilance Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Argentina Pharmacovigilance Market, 2021-2033 (US$M)